Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_assertion type Assertion NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_head.
- NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_assertion description "[We investigated the effect of single-nucleotide polymorphisms (SNPs) spanning 10 methotrexate (MTX) pathway genes, namely AMPD1, ATIC, DHFR, FPGS, GGH, ITPA, MTHFD1, SHMT1, SLC19A1 (RFC) and TYMS on the outcome of MTX treatment in a UK rheumatoid arthritis (RA) patient cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_provenance.
- NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_assertion evidence source_evidence_literature NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_provenance.
- NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_assertion SIO_000772 22450926 NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_provenance.
- NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_assertion wasDerivedFrom befree-20150227 NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_provenance.
- NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_assertion wasGeneratedBy ECO_0000203 NP700897.RAyt0ZTQa7V5PlaEzB8QS56-nOT40jmRJbhMeZiJg2F0U130_provenance.